Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping by Flow Cytometry CD33 Test

The Immunophenotyping by Flow Cytometry CD33 Test helps identify specific cell types in blood or bone marrow, aiding in the diagnosis and management of certain blood cancers like leukemia. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL min.) whole blood in a Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in a Green Top (Sodium Heparin) tube. Alternatively, 2 mL (1 mL min.) of bone marrow in a Green Top (Sodium Heparin) tube.
Results
Confirm with the laboratory before booking.
Preparation
Please provide a brief clinical history when booking the test to assist in accurate interpretation of results. Confirm with the laboratory before booking.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping by Flow Cytometry CD33 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected leukemia or lymphoma
  • ✓Evaluation of unexplained blood count abnormalities
  • ✓Monitoring response to cancer treatment
  • ✓Diagnosis of myelodysplastic syndromes
  • ✓Characterization of acute myeloid leukemia (AML)
  • ✓Investigation of symptoms like fatigue, bruising, or frequent infections
02

In plain language

What this test helps you understand

This test aids in the diagnosis, classification, and monitoring of hematological malignancies, particularly those involving myeloid cells. It helps identify abnormal cell populations and their characteristics, guiding treatment strategies.
The Immunophenotyping by Flow Cytometry CD33 Test is a diagnostic tool used in oncology and hematology. It helps identify and characterize different types of blood cells, particularly in the context of cancer diagnosis. By analyzing the presence of CD33 markers on cell surfaces, healthcare providers can gain insights into hematological malignancies, including leukemias and lymphomas. This test specifically detects CD33, a protein often found on myeloid cells. Using flow cytometry technology, it provides detailed information about cell populations in blood or bone marrow samples. This test is valuable for patients with symptoms suggesting blood disorders or those undergoing treatment for hematological cancers. Results help guide treatment decisions by identifying specific cell types. Interpretation requires expertise from a qualified oncologist or hematologist.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationPlease provide a brief clinical history when booking the test to assist in accurate interpretation of results. Confirm with the laboratory before booking.
Sample3 mL (2 mL min.) whole blood in a Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in a Green Top (Sodium Heparin) tube. Alternatively, 2 mL (1 mL min.) of bone marrow in a Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies the presence of CD33 but requires interpretation alongside other clinical and laboratory findings. Results may be affected by sample handling and quality. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique used to identify cells based on the proteins (antigens) expressed on their surface or inside them. It helps classify cells, especially blood cells.
CD33 is a protein commonly found on the surface of myeloid cells. Its presence or absence can help identify certain types of leukemia and other blood disorders.
The sample is typically collected as a blood draw or a bone marrow aspiration. Specific tubes (Lavender Top/EDTA and Green Top/Sodium Heparin) are required.
Confirm with the laboratory before booking.
A qualified pathologist, oncologist, or hematologist will interpret the results in the context of your clinical history and other test findings.
Fasting is generally not required for this test, but confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp